Latest Breaking News On - ப்ராக்டர் அடித்தளம் - Page 1 : comparemela.com
Common COVID-19 antibiotic flops in clinical trial: Experts weigh in
foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.
Coronavirus Disease Weekly News 18July 2021
econintersect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econintersect.com Daily Mail and Mail on Sunday newspapers.
Broad-spectrum antibiotic no more effective than placebo in preventing COVID-19 symptoms
A UC San Francisco study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease. These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection, said lead author Catherine E. Oldenburg, ScD, MPH, an assistant professor with the UCSF Proctor Foundation. SARS-CoV-2 is the virus that causes COVID-19.
Related Stories
Azithromycin, a broad-spectrum antibiotic, is widely prescribed as a treatment for COVID-19 in the United States and the rest of the world. The hypothesis is that it has anti-inflammatory properties that may help prevent progression if treated early in the disease, said Oldenburg. We did not find this to be the case.
Effect of common COVID antibiotic similar to placebo
ANI
17 Jul 2021, 13:27 GMT+10
California [US], July 17 (ANI): The findings of a new study from UC San Francisco suggests that among non-hospitalized patients the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19. Despite widespread prescription of the antibiotic for the disease, it might increase the chance of hospitalization.
The study, which was conducted in collaboration with Stanford University, appeared in the Journal of the American Medical Association. These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection, said lead author Catherine E. Oldenburg, ScD, MPH, an assistant professor with the UCSF Proctor Foundation. SARS-CoV-2 is the virus that causes COVID-19.
Effect of common Covid-19 antibiotic found similar to that of placebo
Top Searches
Effect of common Covid-19 antibiotic found similar to that of placebo
ANI / Jul 17, 2021, 09:13 IST
FacebookTwitterLinkedinEMail
Representative image
CALIFORNIA: The findings of a new study from UC San Francisco suggests that among non-hospitalized patients the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of Covid-19. Despite widespread prescription of the antibiotic for the disease, it might increase the chance of hospitalization.
The study, which was conducted in collaboration with Stanford University, appeared in the Journal of the American Medical Association. These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection, said lead author Catherine E. Oldenburg, ScD, MPH, an assistant professor with the UCSF Proctor Foundation. SARS-CoV-2 is the virus that causes Covid-19.
vimarsana © 2020. All Rights Reserved.